(Press-News.org) St. Louis, MO (October 14, 2024) According to the Centers for Disease Control, nearly 20% of children and teens are considered obese. Research shows it can have a dramatic impact on a variety of health conditions, including arthritis, heart conditions and other metabolic problems, and the American Academy of Pediatrics now recommends early and intensive treatment to combat obesity. Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity.
Using gene therapy, Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak and Senior Scientist Dr. Ruhang Tang have discovered a revolutionary new way to convert harmful fatty acids into beneficial ones, making it possible for children battling obesity to lower the risk of other health problems, particularly arthritis.
"We’ve learned that the number one preventable risk factor for arthritis in children is being overweight,” said Dr. Guilak. “Our typical response is simply telling kids to lose weight, without addressing the larger issue. Childhood obesity has become an epidemic, and as a result, arthritis is becoming increasingly common in children. One of our key findings is that it’s not just the obesity itself that’s harmful, but also the diet. The types of fatty acids children consume play a significant role in a child’s weight gain. And once children are obese, it opens the door for other significant health problems that can be hard to reverse.”
Dr. Tang said their gene therapy technique involves utilizing an inactive virus, adeno-associated virus (AAV), to deliver the gene for a specific enzyme into cells. The new gene therapy automatically converts highly inflammatory Omega-6 fatty acids to Omega-3 fatty acids, which are better for the body’s metabolic health. Dr. Guilak said Omega-6 acids, which come from fatty foods and vegetable oil such as in fried foods, tend to promote inflammation and can lead to health issues such as arthritis, heart disease, and metabolic problems. Omega-3s, as found in fish and certain nuts, can support a healthier metabolic profile by improving insulin sensitivity, promoting fat metabolism, and reducing inflammation and the risk of obesity-related diseases. Dr. Natalia Harasymowicz, co-lead of the study, said that their gene therapy was also able to lower the number of pro-inflammatory cells that are crucial in promoting obesity-related inflammation and arthritis.
In this study, the researchers studied a type of arthritis that is very common in children, termed “post-traumatic arthritis”, caused by injury to the knee such as a tear in the meniscus tissue that serves as a stabilizer and cushion in the knee. The team found that one injection of the gene therapy significantly decreased the effects of a high-fat, omega-6-rich diet on overall metabolic health and knee arthritis. Of particular interest was the finding that diet-induced obesity led to premature “aging” in these mice, which was prevented by gene therapy.
“What we are observing is that obesity results in old knees in young patients”, said Dr. Guilak. “The modern diet, especially in the United States, tends to be high in Omega-6s and low in Omega-3s, which can lead to an imbalance, especially for kids. The gene therapy we developed will automatically convert omega-6 to omega-3 fatty acids in your body, effectively turning bad fats into good fats. Arthritis can be a very painful and debilitating condition for children so we’re hopeful that this research will help reduce the risk of it developing and make treatments more effective. The implications for how this research might be used in the future are vast but we’re excited about the potential for it to help kids lead healthier lives.”
Dr. Guilak is also the Mildred B. Simon Professor of Orthopaedic Surgery at Washington University in St. Louis and co-Director of the Washington University Center of Regenerative Medicine. His team is working with the Food and Drug Administration (FDA) to head into clinical trials in the next 3-5 years.
This research was supported by Shriners Children’s and the National Institutes of Health.
Ruhang Tang, Natalia S. Harasymowicz, Chia-Lung Wu, Yun-Rak Choi, Kristin Lenz, Sara J. Oswald, Farshid Guilak. Gene therapy for fat-1 prevents obesity-induced metabolic dysfunction, cellular senescence, and osteoarthritis. Proceedings of the National Academy of Sciences USA, [date] 2024.
About Shriners Children’s
Shriners Children’s improves the lives of children by providing pediatric specialty care, conducting innovative research, and offering outstanding education programs for medical professionals. Children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate are eligible for care, regardless of the families’ ability to pay, and receive all care and services in a compassionate, family-centered environment. For more information, please visit shrinerschildrens.org.
###
Cutline: Shriners Children’s St. Louis Advances Groundbreaking Research to Help Combat Childhood
Obesity Epidemic.
Photo credit: Guilak Lab, generated using Bing Image Creator.
END
About The Study: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox.
Corresponding Author: To contact the corresponding author, Jason Zucker, MD, MS, email Jz2700@cumc.columbia.edu.
To access the embargoed study: Visit our For The Media ...
About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed medication since 2021. Injectable PrEP use was low likely because of barriers such as the high cost of stocking this expensive medication in clinics.
Corresponding Author: To contact the corresponding author, Laura M. Mann, PhD, MPH, email lmann@cdc.gov.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.21493)
Editor’s ...
About The Study: Most U.S. hospital websites explicitly included sexual and gender minority (SGM) populations in their nondiscrimination policies, but only a quarter of adult hospitals had an SGM-friendly clinician directory and provided information about SGM-related resources or hospital-based services. Pediatric hospitals more frequently posted SGM-related information than adult hospitals. Hospitals in states with more discriminatory policies were less likely to provide SGM-related information online.
Corresponding Author: To contact the corresponding author, Alex S. Keuroghlian, MD, MPH, email akeuroghlian@mgb.org.
To ...
Study finds use of naloxone by Good Samaritans is up, but not nearly enough
Ohio State and National Registry of EMTs research highlights importance of public’s help in opioid overdose response
COLUMBUS, Ohio – Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open from The Ohio State University College of Medicine, College of Public Health and the National Registry of Emergency Medical Technicians.
In the first study of its kind, the research team looked at national use of naloxone by people without medical training to treat an opioid drug overdose.
“Naloxone ...
About The Study: In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of suicidal ideation or attempts compared with matched patients not prescribed GLP1R who were treated with lifestyle intervention. These results suggest a favorable psychiatric safety profile of GLP1R in adolescents. The detected reduction in hazard ratios for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research.
Corresponding Author: To contact the corresponding author, Liya Kerem, MD, MSc, email liya.em@gmail.com.
To access the ...
About The Study: In this retrospective cohort study of children and adolescents ages 10 to 19, the risk of an incident diagnosis of type 2 diabetes was greater following a COVID-19 diagnosis than in children diagnosed with other respiratory infections. Further study is required to determine whether diabetes persists or reverses later in life.
Corresponding Author: To contact the corresponding author, Pauline Terebuh, MD, MPH, email pdt@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39444)
Editor’s Note: Please see the article for additional information, ...
About The Study: This cross-sectional study of nationally representative registry data found that cancer incidence recovered meaningfully in 2021 following substantial disruptions in 2020. However, incidence rates need to recover further to address the substantial number of patients with undiagnosed cancer during the pandemic.
Corresponding Author: To contact the corresponding author, Uriel Kim, MD, PhD, MBA, email uxk13@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39263)
Editor’s Note: Please ...
Medicare could save up to 74% of the money lost from discarded Alzheimer’s drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away, new research suggests.
The researchers on the study, to be published October 14 in the peer-reviewed JAMA Internal Medicine, estimate that Medicare could waste up to $336 million annually due to discarded medication. Administered dosages are based on each patient’s body weight. But because the drug is currently available ...
When we inhale, airborne chemicals enter our nose, creating the "odor" we detect. These chemicals are then expelled when we exhale. Each breath lasts 3–5 seconds, which seems to limit how quickly we can perceive odors. Chemical changes that occur within a single breath appear to be combined into one odor. Because of this, our sense of smell, or olfaction, is often considered a slow sense.
Now, however, researchers led by Dr. ZHOU Wen from the Institute of Psychology of the Chinese Academy of Sciences have challenged this view. Their new study, ...
Leuven, 14 October 2024 - The human brain’s remarkably prolonged development is unique among mammals and is thought to contribute to our advanced learning abilities. Disruptions in this process may explain certain neurodevelopmental diseases. Now, a team of researchers led by Prof. Pierre Vanderhaeghen (VIB-KU Leuven), together with scientists of Columbia University and Ecole Normale Supérieure has discovered a link between two genes, present only in human DNA, and a key gene called SYNGAP1, which is mutated in intellectual disability and autism spectrum disorders. Their study, published in Neuron, provides a surprisingly direct link between human brain ...
